Mr Duncan Allardyce
| Name | Mr Duncan Allardyce |
|---|---|
| Job title | Lecturer in Chemistry/Biochemistry |
| Research institute | |
| Primary appointment | Natural Sciences |
| Email address | d.allardyce@mdx.ac.uk |
| ORCID | https://orcid.org/0000-0001-7895-2640 |
| Contact category | Academic staff |
Supervision
Employment
Associate lecturer in Biosciences
Middlesex University
01 Oct 2016
01 Jan 2020
Lecturer in Chemistry/Biochemistry
Middlesex University
01 Jan 2020
Education and qualifications
Grants
Prizes and Awards
Research outputs
Identification of a new class of proteasome inhibitors based on a naphthyl-azotricyclic-urea-phenyl scaffold
Allardyce, D., Adu Mantey, P., Szalecka, M., Nkwo, R. and Loizidou, E. 2023. Identification of a new class of proteasome inhibitors based on a naphthyl-azotricyclic-urea-phenyl scaffold. RSC Medicinal Chemistry. 14 (3), pp. 573-582. https://doi.org/10.1039/D2MD00404FIntentionality for inclusivity - the journey at Middlesex University
Roberts, H., Punev, I., Allardyce, D., Kyprianou, A., Appiah, S., Megeney, A., Calin, A., Gallacher, D. and Mill, R. 2022. Intentionality for inclusivity - the journey at Middlesex University. McGraw Hill.Argyrin B a non-competitive inhibitor of the human immunoproteasome exhibiting preference for β1i
Allardyce, D., Bell, C. and Loizidou, E. 2019. Argyrin B a non-competitive inhibitor of the human immunoproteasome exhibiting preference for β1i. Chemical Biology and Drug Design. 94 (2), pp. 1556-1567. https://doi.org/10.1111/cbdd.13539Biochemical and computational studies towards selective inhibition of the immunoproteasome
Allardyce, D. 2018. Biochemical and computational studies towards selective inhibition of the immunoproteasome. Masters thesis Middlesex UniversityAnalysis of argyrin B binding at constitutive and immunoproteasome active sites using molecular modelling and kinetic assays
Allardyce, D., Bell, C. and Loizidou, E. 2017. Analysis of argyrin B binding at constitutive and immunoproteasome active sites using molecular modelling and kinetic assays. Computational Advances in Drug Discovery (Structure Based Drug Design). Lausanne, Switzerland 05 - 08 Sep 2017509
total views of outputs101
total downloads of outputs44
views of outputs this month3
downloads of outputs this month